Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry

Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry

Background: Left atrial appendage closure is a non-pharmacological alternative for stroke prevention in high-risk non-valvular atrial fibrillation patients, but has not been widely studied in Asian patients. The prospective WASP registry assessed real-world outcomes for patients undergoing WATCHMAN...

Full description

Bibliographic Details
Main Authors:	Karen P. Phillips, Teguh Santoso, Prashanthan Sanders, Jeffrey Alison, Jason Leung Kwai Chan, Hui-Nam Pak, Mann Chandavimol, Kenneth M. Stein, Nicole Gordon, Omar Bin Razali
Format:	Article
Language:	English
Published:	Elsevier 2019-06-01
Series:	International Journal of Cardiology: Heart & Vasculature
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906719300272

Similar Items

Watchman Left Atrial Appendage Closure After Incomplete AtriClip Closure
by: Daniel S. Ice, MD, et al.
Published: (2022-04-01)

Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings
by: Henning Ebelt, et al.
Published: (2023-03-01)

Percutaneous left atrial appendage closure with the Watchman device: a systematic review
by: Jakub Maksym, et al.
Published: (2024-03-01)

Circumflex to Left Atrial Appendage Fistula Associated With Watchman FLX Closure Device
by: Stefan Milutinovic, MD, et al.
Published: (2024-02-01)

Percutaneous retrieval of a dislodged watchman left atrial appendage closure device
by: Jiangtao Yu, et al.
Published: (2016-01-01)

Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devices
by: Jin-Yan Ke, et al.
Published: (2022-11-01)

First clinical experience with new left atrial appendage closure device: WATCHMAN FLX® System
by: Xin Xue, et al.
Published: (2016-01-01)

Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure
by: Nobuyuki Fukuda, et al.
Published: (2022-03-01)

Percutaneous Left Appendage Closure with the Watchman Device; The Challenges Lie Ahead: A Narrative Mini Review
by: Mohammad Hasan Namazi, et al.
Published: (2018-05-01)

Surgical retrieval of a left atrial appendage closure device (Watchman TM) following embolization into the mitral valve
by: Kevin P Birmingham, et al.
Published: (2019-01-01)

Successful Left Atrial Appendage Closure with Watchman Device Implantation in Two Patients with Inferior Vena Cava Filters
by: Fabricio Vassallo, et al.
Published: (2021-12-01)

Successful Left Atrial Appendage Closure with Watchman Device Implantation in Two Patients with Inferior Vena Cava Filters
by: Fabricio Vassallo, et al.
Published: (2021-12-01)

Successful Left Atrial Appendage Closure with Watchman Device Implantation in Two Patients with Inferior Vena Cava Filters
by: Fabricio Vassallo, et al.
Published: (2021-12-01)

Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure)
by: Lucie Kretzler, et al.
Published: (2022-06-01)

Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry
by: Sergio Berti, et al.
Published: (2023-04-01)

Safety and efficacy of transcatheter left atrial appendage closure using the Watchman device in Egyptian patients with nonvalvular atrial fibrillation
by: Hazem Khamis, et al.
Published: (2016-03-01)

Left atrial appendage closure with Watchman device in prevention of thromboembolic complications in patients with atrial fibrillation: First experience in Serbia
by: Nedeljković Milan A., et al.
Published: (2017-01-01)

Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
by: Alipour A, et al.
Published: (2017-03-01)

Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience
by: Mohammed Saad, et al.
Published: (2021-12-01)

Left atrial enlargement and clinical considerations in patients with or without a residual interatrial shunt after closure of the left atrial appendage with the WATCHMAN™-device
by: Blerim Luani, et al.
Published: (2017-12-01)

Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience
by: Karen P. Phillips, MBBS, et al.
Published: (2016-04-01)

Safety and efficacy of percutaneous atrial appendage closure followed by antiplatelet therapy in a high-risk population: single-center experience with a WATCHMAN device
by: Jakub Maksym, et al.
Published: (2023-09-01)

Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device
by: Guohua Fu, et al.
Published: (2022-08-01)

Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device
by: Blerim Luani, et al.
Published: (2019-05-01)

Watchman /
by: 532064 Rankin, Ian
Published: (2003)

First results of the Brazilian Registry of Percutaneous Left Atrial Appendage Closure
by: Ênio Eduardo Guérios, et al.
Published: (2017-10-01)

Comparison of intracardiac vs. transesophageal echocardiography for “one-stop” procedures of combined radiofrequency catheter ablation and left atrial appendage closure with the Watchman device in the treatment of atrial fibrillation
by: Xining Shang, et al.
Published: (2023-11-01)

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection In Patients With Atrial Fibrillation) trial
by: Gaurav Mohan, et al.
Published: (2013-05-01)

Intra-Cardiac versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion with a Watchman FLX Device
by: Luigi Emilio Pastormerlo, et al.
Published: (2023-10-01)

Indications and Outcome in Patients Undergoing Left Atrial Appendage Closure—The Austrian LAAC Registry
by: David Zweiker, et al.
Published: (2020-10-01)

Major Bleeding Predictors in Patients with Left Atrial Appendage Closure: The Iberian Registry II
by: José Ramón López-Mínguez, et al.
Published: (2020-07-01)

Occlusion of Bilobulated Left Atrial Appendage Using the Dual-Watchman Technique: A Long-Term Follow-Up Study
by: Tao Chen, et al.
Published: (2022-03-01)

The Watchman FLX – a new device for left atrial appendage occlusion – design, potential benefits and first clinical experience
by: Marek Grygier, et al.
Published: (2017-03-01)

Go Set a Watchman:
by: Sohana Manzoor
Published: (2016-12-01)

Transjugular left atrial appendage closure
by: Juan Gabriel Córdoba-Soriano, et al.
Published: (2024-02-01)

Left Atrial Appendage Closure Devices
by: Jorge Romero, et al.
Published: (2014-06-01)

Left Atrial Appendage Closure Devices
by: Jorge Romero, et al.
Published: (2014-01-01)

Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis
by: Farah Yasmin, et al.
Published: (2024-01-01)

Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry
by: Ignacio Cruz-González, et al.
Published: (2022-02-01)

Combined MitraClip implantation and left atrial appendage occlusion using the Watchman device: A case series from a referral center
by: Ana Rita G. Francisco, et al.
Published: (2017-07-01)